Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avigen, Inc.
Deal signed with pain expert to develop neuropathic pain therapy
June 22nd, 2005
Avigen, Inc., (AVGN), a leader in the development of innovative therapies for the treatment of chronic neurological conditions, announced that a feature report in Science Magazine, supports the scientific research and therapeutic development the company has championed of the important role glial cells play in controlling chronic pain. Avigen's leading collaborator in the treatment of neuropathic pain, Linda Watkins, PhD, a noted pain specialist, and professor of Psychology and director, Interdepartmental Neuroscience Program at the University of Colorado at Boulder, was prominently featured in the report for her acclaimed "contributions to understanding the mechanisms...
Source: Physician Law Weekly (2005-06-22)
|
